サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1661279

人工臓器の市場規模、シェア、動向、予測：タイプ別、地域別、2025年～2033年

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 134 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
人工臓器の市場規模、シェア、動向、予測：タイプ別、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 134 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工臓器の市場の世界市場規模は2024年に222億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに445億米ドルに達し、2025年から2033年にかけてCAGR 7.22%の成長率を示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは45.0%を超えています。臓器拒絶反応のリスクを最小化する能力、がん、糖尿病、高血圧、脳卒中、心臓病、呼吸器疾患などの慢性疾患の有病率の上昇、臓器移植の需要の高まりにより、3Dバイオプリンティングのニーズが高まっています。

生体材料は、従来の金属、鉱物、合成ベースの材料と比較して、高い導電性、強度、生体適合性、生体分解性を提供します。その結果、人工臓器への先端バイオマテリアルの採用が増加しており、これが現在、市場成長の主な促進要因の1つとなっています。これに加えて、医療機器、組織工学、ドラッグデリバリー、遺伝子デリバリー、低侵襲手術（MIS）、バイオセンサーにおける生体材料の利用も増加しています。これとは別に、世界中の個人の間で臓器不全や疾患が増加しているため、人工臓器における生体材料の需要が高まっており、市場にプラスの影響を与えています。

市場構造、主要企業による市場シェア、主要企業の市況分析、主要成功戦略、競合ダッシュボード、企業評価象限などの競合分析が本レポートで取り上げられています。また、主要企業の詳細プロファイルも掲載しています。市場構造は細分化されており、多数の国際的・地域的企業が業界で活動しています。人工臓器業界では、製品の差別化やスイッチングコストが低いため、新規参入の動きは緩やかです。しかし、厳しい政府の規制と政策、高い投資コストが、人工臓器市場への新規参入を妨げています。

人工臓器とは何か？

人工臓器は、元の臓器の代わりとして人体に移植されるように設計された人工装置です。人工臓器は、金属、無生物ポリマー、生きた細胞、幹細胞を播種したプラスチックなど、さまざまな材料を使って製造されます。腎臓、肺、肝臓、心臓、人工膵臓、人工内耳などがあります。人工臓器は身体の免疫システムが拒絶反応を示さないため、身体に非常に適しています。重篤な臓器不全の患者を維持するために、電源やその他の据置型資源に継続的に繋ぎとめる必要はないです。人工臓器は、健康な臓器と同じような機能を提供したり、特定の機能を果たすのを助ける。また、移植を待つ間、差し迫った死を防ぐための生命維持にも役立ちます。このほかにも、美容整形、がん手術後、事故後などの患者の生活を改善するのにも有益です。人工臓器は個人の命を救い、活動を助けるため、世界中で需要が高まっています。

COVID-19の影響：

COVID-19パンデミックの発生は、多くの産業に深刻な問題を引き起こし、さまざまな国に前例のない課題を課しました。人工臓器は必要不可欠な製品であるため、人工臓器産業はパンデミックによって深刻な影響を受けることはありません。この産業の生産施設やユニットは閉鎖されなかった。しかし、人工臓器の製造は、パンデミックの初期には、原材料業界からのサプライチェーンが寸断されたために影響を受けた。これに伴い、ウイルスの蔓延を恐れて労働力が不足し、COVID-19パンデミックの初期には人工臓器の市場に影響を与えました。これとは別に、各国の行政機関が路上での移動に厳しい規則や規制を課したため、物流・輸送業界は支障をきたしました。このことは、人工臓器業界にとって短期的にはサプライチェーンに一時的な影響を与えました。さらに、世界中で移植治療と診断の割合が低下したため、主要企業は生産能力の縮小を余儀なくされ、パンデミックの間、かなりの経済的損失に直面しました。これに加えて、国境を越えた制限や、世界中の商品やサービスの輸出入といった貿易活動の禁止により、人工臓器の需要が減少しました。加えて、人工臓器を体内に埋め込むことよりも、コロナウイルスに関連した治療の選択肢の方が注目されていました。しかし、閉鎖措置の再開後、人工臓器の需要は今後増加すると予想されます。

人工臓器の市場動向：

現在、世界中で臓器提供者が減少しているため、人工臓器に対する需要が増加しており、これが市場にプラスの影響を与えている主な要因の1つとなっています。また、世界中で臓器不全や障害者が増加していることから、人工臓器の採用が増加しており、市場の成長に寄与しています。これとは別に、ウェアラブル技術、マイクロチップ技術、非侵襲的診断技術など、医療機器におけるさまざまな技術的進歩が、市場に明るい展望をもたらしています。これに加えて、高強度、導電性、生体適合性を提供するために人工臓器で先端生体材料の利用が増加しており、業界の投資家に有利な成長機会を提供しています。さらに、世界中の個人の生活を向上させるのに非常に適した人工臓器に対する需要が増加しています。これは、生活習慣やライフスタイルの変化による大衆の生活習慣関連疾患の増加と相まって、市場の成長を後押ししています。これに伴い、精密診断による人工臓器のモニタリングに対する嗜好が高まっていることも、市場の成長を後押ししています。さらに、主要企業は人工臓器に人工知能（AI）と組み込みセンサーを導入しており、これが市場の成長を強化しています。

本レポートで扱う主な質問

  • 人工臓器とは何か？
  • 人工臓器の市場の市場規模は？
  • 2025-2033年の世界の人工臓器の市場の予想成長率は？
  • 世界の人工臓器の市場を牽引する主要因は何か？
  • 世界の人工臓器の市場のタイプ別主要セグメントは？
  • 世界の人工臓器の市場の主要地域は？
  • 世界の人工臓器の市場の主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の人工臓器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：タイプ別
  • 市場内訳：地域別
  • 市場予測
  • SWOT分析
    • 概要
    • 強み
    • 弱み
    • 機会
    • 脅威
  • バリューチェーン分析
    • 概要
    • 研究開発
    • 原材料調達
    • 製造
    • マーケティング
    • 流通
    • 最終用途
  • ポーターのファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合の程度
    • 新規参入業者の脅威
    • 代替品の脅威

第6章 市場内訳：タイプ別

  • 人工腎臓
    • 市場動向
    • 市場予測
  • 人工心臓
    • 市場動向
    • 市場予測
  • 人工膵臓
    • 市場動向
    • 市場予測
  • 人工内耳
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：地域別

  • アジア太平洋地域
  • 北米
  • 欧州
  • 中東・アフリカ
  • ラテンアメリカ

第8章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abiomed, Inc.
    • HeartWare International, Inc.
    • Edwards Lifesciences Corp
    • Boston Scientific Corporation
    • Cochlear Limited
図表

List of Figures

  • Figure 1: Global: Artificial Organs Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Organs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Organs Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Artificial Organs Market: Breakup by Region (in %), 2024
  • Figure 5: Global: Artificial Organs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 6: Global: Artificial Organs Industry: SWOT Analysis
  • Figure 7: Global: Artificial Organs Industry: Value Chain Analysis
  • Figure 8: Global: Artificial Organs Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Artificial Organs (Artificial Kidney) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Artificial Organs (Artificial Kidney) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Artificial Organs (Artificial Heart) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Artificial Organs (Artificial Heart) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Artificial Organs (Artificial Pancreas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Artificial Organs (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Artificial Organs (Cochlear Implants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Artificial Organs (Cochlear Implants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Artificial Organs (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Artificial Organs (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Europe: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Europe: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia Pacific: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia Pacific: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Middle East and Africa: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Middle East and Africa: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Latin America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Latin America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Artificial Organs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Organs Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Organs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 4: Global: Artificial Organs Market Structure
  • Table 5: Global: Artificial Organs Market: Key Players
目次
Product Code: SR112025A833

The global artificial organs market size reached USD 22.2 Billion in 2024. Looking forward, the IMARC Group expects the market to reach USD 44.5 Billion by 2033, exhibiting a growth rate CAGR of 7.22% during 2025-2033. North America currently dominates the market, holding a market share of over 45.0% in 2024. The increasing need for 3D bioprinting due to its capability to minimize the risk of organ rejection, rising prevalence of chronic diseases, such as cancer, diabetes, hypertension, stroke, heart disease, and respiratory diseases, and escalating demand for organ transplantation.

Biomaterials offer high conductivity, strength, bio-compatibility, and bio-degradability as compared to conventional metal, mineral, and synthetic-based materials. As a result, there is a rise in the adoption of advanced biomaterials in artificial organs, which currently represents one of the primary drivers contributing to the growth of the market. In addition to this, there is an increase in the utilization of biomaterials in medical devices, tissue engineering, drug and gene delivery, minimally invasive surgery (MIS), and biosensors. Apart from this, the growing demand for biomaterials in artificial organs due to the increasing number of organ failures and diseases among individuals across the globe is positively influencing the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented in nature with a large number of international and regional players operating in the industry. The volume of new entrants is moderate in the artificial organs industry on account of the low product differentiation and switching costs. However, stringent government policies and regulations and high investment costs hinder the entry of new entrants in the artificial organ market.

What are Artificial Organs?

Artificial organs are engineered devices designed to be implanted in a human body as an alternative to the original organ. They are manufactured through various materials, such as metals, inanimate polymers, living cells, and plastic seeded with stem cells, that are obtained from the transplant recipient. They are widely available as kidney, lung, liver, heart, and artificial pancreas, and cochlear implants. They are highly suitable for the body as the immune system of the body does not reject the artificial organ. They do not require continuous tethering to a power supply or any other stationary resource to keep patients with serious organ failure. They assist in providing similar functions of a healthy organ or performing a specific function. They also aid in offering life support to prevent imminent death while waiting for a transplant. Besides this, it is beneficial in improving the life of a patient through cosmetic restoration, post-cancer surgery or an accident. As they save the life of individuals and aid in performing activities, the demand for artificial organs is rising across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak has caused severe problems for numerous industries and imposed unprecedented challenges on various countries. The artificial organ industry was not severely hampered by the pandemic as these are essential products. The production facilities or units of the industry were not shut down. Although, the manufacturing of artificial organs has been affected in the initial period of the pandemic on account of the supply chain disruptions from the raw materials industry. In line with this, there was a shortage of labor due to the fear of the widespread virus, which impacted the artificial organs market in the starting months of the COVID-19 pandemic. Apart from this, governing agencies of various countries have imposed stringent rules and regulations on on-road movement, which hampered the logistical and transportation industry. This has temporarily impacted the supply chain in the short term for the artificial organs industry. Moreover, there was a lower rate of transplant treatment and diagnostic across the globe that forced key players to descale their production capacity, and they faced some considerable financial losses during the pandemic. Besides this, there was a declined demand for artificial organs on account of the cross-border restrictions and bans on trade activities, such as imports and exports of goods and services around the world. Additionally, people were more focused on the treatment options related to the coronavirus as compared to implanting artificial organs in the body. However, after the reopening of lockdown measures, the demand for artificial organs is expected to increase in the coming years.

Artificial Organs Market Trends:

At present, the increasing demand for artificial organs due to the decreasing number of organ donors around the world represents one of the major factors influencing the market positively. Additionally, the rising adoption of artificial organs due to the increasing number of organ failures and disabilities among individuals across the globe is contributing to the growth of the market. Apart from this, various technological advancements in medical devices, such as wearable technology, microchips technology, and non-invasive diagnostic techniques, are offering a positive market outlook. In addition to this, the increasing utilization of advanced biomaterials in artificial organs to provide high strength, conductivity, and bio-compatibility is offering lucrative growth opportunities to industry investors. Moreover, there is a rise in demand for artificial organs that are highly suitable to enhance the lives of individuals around the world. This, coupled with the growing number of lifestyle-related diseases among the masses due to the changing habits and lifestyles, is bolstering the growth of the market. In line with this, the rising preference for monitoring artificial organs by using precise diagnostics is impelling the growth of the market. Furthermore, key players are introducing artificial intelligence (AI) and embedded sensors in artificial organs, which is strengthening the growth of the market.

Key Market Segmentation:

Type Insights:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for artificial organs. Some of the factors driving the North America artificial organs market included the growing prevalence of organ failures and disabilities among the masses, rising adoption for the treatment of several cancers, and increasing number of diseases and low availability of organ donors. In addition to this, key players operating in the region are introducing miniature heart pump devices that provide smart patient management for enhanced patient experience, which is contributing to the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global artificial organs market. Some of the companies covered in the report include:

  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited
  • Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What are artificial organs?
  • 2.How big is the artificial organs market?
  • 3.What is the expected growth rate of the global artificial organs market during 2025-2033?
  • 4.What are the key factors driving the global artificial organs market?
  • 5.What is the leading segment of the global artificial organs market based on the type?
  • 6.What are the key regions in the global artificial organs market?
  • 7.Who are the key players/companies in the global artificial organs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Organs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Region
  • 5.6 Market Forecast
  • 5.7 SWOT Analysis
    • 5.7.1 Overview
    • 5.7.2 Strengths
    • 5.7.3 Weaknesses
    • 5.7.4 Opportunities
    • 5.7.5 Threats
  • 5.8 Value Chain Analysis
    • 5.8.1 Overview
    • 5.8.2 Research and Development
    • 5.8.3 Raw Material Procurement
    • 5.8.4 Manufacturing
    • 5.8.5 Marketing
    • 5.8.6 Distribution
    • 5.8.7 End-Use
  • 5.9 Porters Five Forces Analysis
    • 5.9.1 Overview
    • 5.9.2 Bargaining Power of Buyers
    • 5.9.3 Bargaining Power of Suppliers
    • 5.9.4 Degree of Competition
    • 5.9.5 Threat of New Entrants
    • 5.9.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Artificial Kidney
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Artificial Heart
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Artificial Pancreas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cochlear Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Europe
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Asia Pacific
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Middle East and Africa
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Latin America
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Key Players
  • 8.3 Profiles of Key Players
    • 8.3.1 Abiomed, Inc.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Description
      • 8.3.1.3 Product Portfolio
      • 8.3.1.4 Financials
      • 8.3.1.5 SWOT Analysis
    • 8.3.2 HeartWare International, Inc.
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Description
      • 8.3.2.3 Product Portfolio
      • 8.3.2.4 Financials
      • 8.3.2.5 SWOT Analysis
    • 8.3.3 Edwards Lifesciences Corp
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Description
      • 8.3.3.3 Product Portfolio
      • 8.3.3.4 Financials
      • 8.3.3.5 SWOT Analysis
    • 8.3.4 Boston Scientific Corporation
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Description
      • 8.3.4.3 Product Portfolio
      • 8.3.4.4 Financials
      • 8.3.4.5 SWOT Analysis
    • 8.3.5 Cochlear Limited
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Description
      • 8.3.5.3 Product Portfolio
      • 8.3.5.4 Financials
      • 8.3.5.5 SWOT Analysis